目的 :探讨玻璃酸钠治疗髌骨软化症的临床效果。方法 :对患有原发性髌骨软化症的 2 1关节行关节腔内注射玻璃酸钠 ,每周给药 1次 ,每次 2ml,连续给药 3周。对其中的 17例进行了为期 3个月的随访。结果 :治疗后症状改善优良率 2 8.6 % ,良好率为 6 6 .7% ,未观察到明显的毒副作用。结论 :玻璃酸钠治疗髌骨软化症疗效确切 ,为一种安全可行的治疗方法 Objective: To investigate the clinical effect of sodium hyaluronate on chondromalacia patellae. METHODS: 21 patients with primary chondromalacia patella were treated with intra-articular injection of sodium hyaluronate once a week for 2 weeks for 3 weeks. Of these 17 cases were followed up for 3 months. Results: After treatment, the rate of symptom improvement was 22.6% and the good rate was 6.6%. No obvious side effects were observed. Conclusion: Sodium hyaluronate for the treatment of chondromalacia patella is effective and safe, which is a safe and feasible treatment